Literature DB >> 8276243

IGF-I is required for normal embryonic growth in mice.

L Powell-Braxton1, P Hollingshead, C Warburton, M Dowd, S Pitts-Meek, D Dalton, N Gillett, T A Stewart.   

Abstract

IGF-I is a pleiotropic hormone reported to affect linear growth, glucose metabolism, organ homeostasis, and the immune and neurologic systems. In contrast to IGF-II, IGF-I is expressed at low levels embryonically and has been thought to be more important for postnatal growth and development. To investigate the role of IGF-I in normal development we generated mice with an inactive IGF-I gene by homologous recombination in ES cells. Heterozygous mice are healthy and fertile, but they are 10-20% smaller than wild-type littermates and have lower than normal levels of IGF-I. The size reduction is attributable to a decrease in organs and muscle and bone mass. However, all tissues appear histologically normal. At birth homozygous mutant mice (IGF-I-/-) are < 60% body weight of wild type. Greater than 95% of IGF-I-/- pups die perinatally. Histopathology is characterized by underdevelopment of muscle tissue. Lungs of late embryonic and neonates also appeared less organized with ill-defined alveolae. IGF-I appears to be essential for correct embryonic development in mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276243     DOI: 10.1101/gad.7.12b.2609

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  199 in total

Review 1.  The role of circulating IGF-I: lessons from human and animal models.

Authors:  Shoshana Yakar; Yiping Wu; Jennifer Setser; Clifford J Rosen
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Tissue-specific targeting of the insulin receptor gene.

Authors:  Rohit N Kulkarni; Terumasa Okada
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

Authors:  Subburaman Mohan; Charmaine Richman; Rongqing Guo; Yousef Amaar; Leah Rea Donahue; Jon Wergedal; David J Baylink
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

Review 4.  Insulin-like growth factor (IGF)-I gene deletion.

Authors:  Cecilia Camacho-Hübner; Katie A Woods; Adrian J L Clark; Martin O Savage
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

5.  Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis.

Authors:  F M Rausa; Y Tan; H Zhou; K W Yoo; D B Stolz; S C Watkins; R R Franks; T G Unterman; R H Costa
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.

Authors:  Alexias Safi; Marie Vandromme; Sabine Caussanel; Laure Valdacci; Dominique Baas; Marc Vidal; Gilbert Brun; Laurent Schaeffer; Evelyne Goillot
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Antisense oligonucleotides shed new light on the pathogenesis and treatment of spinal muscular atrophy.

Authors:  Jiing-Kuan Yee; Ren-Jang Lin
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

8.  Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep.

Authors:  Laura D Brown; Paul J Rozance; Stephanie R Thorn; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

Review 9.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

10.  Disruption of the Fbxw8 gene results in pre- and postnatal growth retardation in mice.

Authors:  Takeya Tsutsumi; Hiroshi Kuwabara; Takehiro Arai; Yonghong Xiao; James A Decaprio
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.